Effects of Aromatherapy on Anxiety and Pain During Dental Treatment in Adults

May 13, 2025 updated by: He Cai, Sichuan University

Effects of Aromatherapy on Anxiety and Pain During Dental Treatment in Adults: a Randomized Controlled Clinical Trial

Dental anxiety is a common problem in dental care. The aim of this protocol is to evaluate the effect of orange and tea essential oil for the control of anxiety and pain in adults during dental treatments.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Sichuan
      • Chengdu, Sichuan, China, 610041
        • Recruiting
        • West China Hospital of Stomatology Sichuan University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Patients who need dental treatment, such as resin filling, root canal treatment, periodontal initial treatment, tooth extraction, etc.
  • Be able to understand the purpose of the study and volunteer to take part in the study.
  • Be able to complete all assessments and follow-up during the study.

Exclusion Criteria:

  • Patients who are allergic to the ingredients of the essential oils used in the experiment or to the materials used in the dental treatment.
  • Patients who underwent only an oral examination.
  • Patients with severe heart disease, hypertension, respiratory disease, or other systemic conditions that were not eligible for trial participation.
  • Pregnant or lactating women.
  • People with depressive symptoms, anxiety disorders or other mental illnesses that affect their mood state.
  • People who are using sedative or analgesic drugs.
  • Recent or current users of essential oil.
  • Any circumstances considered by the investigator to be inappropriate for participation in this study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group 1: single-note sweet orange essential oil
In a space of 3*4*2.6 cubic meters, positioned 10 cm away from the patient, add 4-6 drops (each drop being 0.05 ml) of 100% concentration single-note sweet orange essential oil into the aroma diffuser reservoir containing 120 ml of water.
Experimental: Group 2: single-note tea tree essential oil
In a space of 3*4*2.6 cubic meters, positioned 10 cm away from the patient, add 4-6 drops (each drop being 0.05 ml) of 100% concentration single-note tea tree essential oil into the aroma diffuser reservoir containing 120 ml of water.
Sham Comparator: Group 3: water
In a space of 3*4*2.6 cubic meters, positioned 10 cm away from the patient, add 4-6 drops (each drop being 0.05 ml) of water into the aroma diffuser reservoir containing 120 ml of water.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Anxiety scale 1 - Modified Dental Anxiety Scale (MDAS)
Time Frame: 5 minutes before operation/during operation (immediately after the most painful procedure)/immediately after operation
The Modified Dental Anxiety Scale (MDAS) consists of 4 questions each with a 5 category rating scale, ranging from 'not anxious' to 'extremely anxious', hence, the total score varies from 4 to 20, with higher obtained scores describing more elevated levels of dental anxiety. MDAS is recorded before, during and after operation.
5 minutes before operation/during operation (immediately after the most painful procedure)/immediately after operation
Pain scale - Visual Analog Scale (VAS)
Time Frame: 5 minutes before operation/during operation (immediately after the most painful procedure)/immediately after operation
The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between "no pain" and "worst pain." VAS is recorded before, during and after operation.
5 minutes before operation/during operation (immediately after the most painful procedure)/immediately after operation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Anxiety scale 2 - State-Trait Anxiety Inventory for State Anxiety (STAI-S)
Time Frame: 5 minutes before operation/ immediately after operation
The STAI-S evaluates the subjective feelings of tension, worry, nervousness, apprehension, and autonomic nervous system activation. This self-completed inventory consisted of 20 items on a four-point Likert scale running from one (i.e., not at all) to four (i.e., very much). Hence, the total score varies from 20 to 80, with higher obtained scores describing more elevated levels of anxiety. STAI-S is recorded before and after operation,
5 minutes before operation/ immediately after operation
Vital sign 1 - systolic blood pressure (SBP)
Time Frame: 5 minutes before operation/during operation (immediately after the most painful procedure, and every 10min after)/immediately after operation
systolic blood pressure (SBP) is measured using a manual sphygmomanometer, before, during and after operation.
5 minutes before operation/during operation (immediately after the most painful procedure, and every 10min after)/immediately after operation
Vital sign 2 - diastolic blood pressure (DBP)
Time Frame: 5 minutes before operation/during operation (immediately after the most painful procedure, and every 10min after)/immediately after operation
diastolic blood pressure (DBP) is measured using a manual sphygmomanometer, before, during and after operation.
5 minutes before operation/during operation (immediately after the most painful procedure, and every 10min after)/immediately after operation
Vital sign 3 - heart rate (HR)
Time Frame: 5 minutes before operation/during operation (immediately after the most painful procedure, and every 10min after)/immediately after operation
Heart rate (HR)is measured as pulse rate using an oximeter, before, during and after operation.
5 minutes before operation/during operation (immediately after the most painful procedure, and every 10min after)/immediately after operation
Vital sign 4 - oxygen saturation (SpO2)
Time Frame: 5 minutes before operation/during operation (immediately after the most painful procedure, and every 10min after)/immediately after operation
oxygen saturation (SpO2)is measured using an oximeter, before, during and after operation.
5 minutes before operation/during operation (immediately after the most painful procedure, and every 10min after)/immediately after operation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2024

Primary Completion (Estimated)

May 1, 2026

Study Completion (Estimated)

September 1, 2026

Study Registration Dates

First Submitted

March 28, 2024

First Submitted That Met QC Criteria

March 28, 2024

First Posted (Actual)

April 4, 2024

Study Record Updates

Last Update Posted (Actual)

May 16, 2025

Last Update Submitted That Met QC Criteria

May 13, 2025

Last Verified

May 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • WCHSIRB-CT-2024-160

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dental Anxiety

Clinical Trials on Aroma diffuser with single-note sweet orange essential oil

Subscribe